Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Oct 19, 2021 10:00 AM - Oct 20, 2021 5:00 PM

(US Eastern Standard Time)

DIA Canadian Annual Meeting

The Canadian Annual Meeting now includes a track for Pharmacovigilence and Risk Management Strategies!

Session 5 Track C: Utility of Artificial Intelligence in Pharmacovigilance

Session Chair(s)

Caroline  Croteau, PhD, RPh

Caroline Croteau, PhD, RPh

Country Safety Lead

Pfizer Canada Inc, Canada

Pharmaceutical companies are actively pursuing automated solutions to address the challenge of managing increasing volumes of safety-related data from multiple sources. Different Artificial Intelligence (AI) and technology tools – such as robotic process automation (RPA), and natural language processing (NLP) are being assessed and applied by different companies across the pharmacovigilance (PV) continuum. Validation of such applications remains an area of focus with interest from Regulatory Agencies worldwide. This session will provide an overview of the potential uses of AI in pharmacovigilance activities, provide concrete examples from the Pharma Industry as well as Health Canada’s view on the topic and results from a survey conducted on this subject earlier this year.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand how AI can be leveraged in pharmacovigilance and define AI, RPA, and NLP
  • Outline how pharma organizations are using AI as part of PV activities, including limitations and validation
  • Understand Health Canada’s regulatory perspective on applying AI to pharmacovigilance strategies

Speaker(s)

Claudia  Schaffer, RN

Intelligent Automation Opportunities in Pharmacovigilance – The TranCelerate Group

Claudia Schaffer, RN

EMD Serono, Germany

Sr. Director, Head Case and Vendor Management

Oeystein  Kjoersvik, MS, MSc

Speaker

Oeystein Kjoersvik, MS, MSc

Merck Sharp & Dohme LLC, Czech Republic

Technology Auditor and Quality Projects Lead

Bhavin  Patel, PharmD, RPh

Embrace Automation in Pharmacovigilance – COVID-19 Vaccine Experience

Bhavin Patel, PharmD, RPh

Pfizer Inc., United States

Senior Director, Drug Safety

John Reinhard Pietzsch, DrSc

Applied Data Science in Modern Pharmacovigilance

John Reinhard Pietzsch, DrSc

Bayer AG, Germany

Head of PV Data Science & Insight Generation

Marc-André  Giguère

Health Canada Regulatory Perspective and Industry Survey

Marc-André Giguère

Health Canada, Canada

Senior Policy Analyst

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.